Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.
SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.
Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study.
JAK-STAT Pathway: A Novel Target to Tackle Viral Infections.
-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants.
Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy
New Drugs, Old Toxicities: Pneumonitis Related to Palbociclib - A Case Report.
Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy.
Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial.